S'abonner

Human activities and climate change in the emergence of vector-borne diseases - 19/11/19

Doi : 10.1016/j.crvi.2019.09.023 
Anna-Bella Failloux
 Arboviruses and Insect Vectors Laboratory, Department of Virology, Institut Pasteur, Paris, France 

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

pages 2
Iconographies 1
Vidéos 0
Autres 0

Résumé

Because of human population expansion and activities, arthropod-borne viruses (arboviruses) have increased in importance during these last decades. Arboviruses are maintained by alternate replication in both vertebrate hosts and arthropod vectors. Successful transmission relies on a complex life cycle in the vector, which starts when a competent arthropod ingests an infectious blood meal from a viremic vertebrate host. Following an extrinsic incubation time during which the virus replicates in the vector midgut, followed by systemic viral dissemination to the salivary glands, the vector can transmit the virus to a new naïve host. Whereas they typically cause self-limiting, acute infections in their vertebrate hosts, arboviruses establish persistent infections in their vectors.

Arboviruses are typically maintained within an enzootic cycle between wild animals and vectors. As human populations encroach on regions where these diseases are endemic, spillover transmission to humans and domestic animals can lead to large-scale disease outbreaks affecting millions of people. Dengue, chikungunya, Zika, and yellow fever mainly use humans as amplification hosts. Extensive urbanization combined with increased commerce and travel give rise to the mosquitoes Aedes aegypti and Aedes albopictus, both highly adapted to the human environment. The high densities of these human-biting mosquitoes that proliferate in highly populated cities made the bed to explosive outbreaks of arboviral diseases. As insects are ectothermic organisms, climate change may affect the geographical distribution of vectors, with consequences on the transmission of arboviruses.

Yellow fever (YF) is a good example of an emerging arbovirus, as it illustrates three main steps in the emergence: (i) introduction of a new pathogen in a new environment causing urban outbreaks, (ii) spillback of this pathogen into the wild initiating an enzootic cycle, and (iii) the spillover of this pathogen from an enzootic cycle to initiate an urban cycle (Fig. 1).

YF (YFV, Flavivirus, Flaviviridae) is a disease endemic to tropical regions of Africa and South America. There are seven lineages: five in Africa and two in America. Each year, 200,000 cases and 30,000 deaths were reported. In 2016, YFV emerged in Angola and imported cases were detected outside Africa, posing the threat of emergence of this virus outside Africa and Americas (Amraoui et al. Euro Surveill 2016).

YFV was introduced into the New World during the slave trade, causing devastating outbreaks in several American countries, including cities like New York City and Boston. Once Carlos Finlay and Walter Reed had demonstrated that the YFV was transmitted by a mosquito, Ae. aegypti, eradication campaigns of the vector were initiated, leading to the control of YF.

In Brazil, Ae. aegypti was eradicated in 1954. YF disappeared from cities and only persisted in a sylvatic cycle where YFV circulated between zoophilic mosquitoes (Hemagogus and Sabethes) and non-human primates. Using experimental infections, we showed that the zoophilic mosquitoes (Hemagogus leucocelaenus and Sabethes albiprivus) were able to transmit YFV at very high rates (Couto-Lima et al. Sci Rep 2017). With the relaxation of control measures in Brazil, Ae. aegypti was reintroduced in 1967 and Ae. albopictus in 1986. We showed that Ae. aegypti and Ae. albopictus were highly susceptible to YFV. We also demonstrated that using a protocol of experimental selection, we were able to select a YFV well adapted to a transmission by Ae. albopictus (Amraoui et al. Sci Rep 2018). This result should alert about the potential of YFV to initiate an urban cycle in Brazil, like in the past.

Le texte complet de cet article est disponible en PDF.

Plan


© 2019  Publié par Elsevier Masson SAS de la part de Académie des sciences.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 342 - N° 7-8

P. 269-270 - septembre 2019 Retour au numéro
Article précédent Article précédent
  • Do we have to get rid of mosquitoes to eliminate malaria?
  • Markus Gildenhardt, Elena Levashina
| Article suivant Article suivant
  • Benefits and limitations of emerging techniques for mosquito vector control
  • Catherine Golstein, Pascal Boireau, Jean-Christophe Pagès, on behalf of the Scientific Committee of the High Council for Biotechnology in France

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.